1. Home
  2. EMBC vs IRMD Comparison

EMBC vs IRMD Comparison

Compare EMBC & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • IRMD
  • Stock Information
  • Founded
  • EMBC 1924
  • IRMD 1992
  • Country
  • EMBC United States
  • IRMD United States
  • Employees
  • EMBC N/A
  • IRMD N/A
  • Industry
  • EMBC Medical/Dental Instruments
  • IRMD Medical/Dental Instruments
  • Sector
  • EMBC Health Care
  • IRMD Health Care
  • Exchange
  • EMBC Nasdaq
  • IRMD Nasdaq
  • Market Cap
  • EMBC 719.1M
  • IRMD 662.5M
  • IPO Year
  • EMBC N/A
  • IRMD 2014
  • Fundamental
  • Price
  • EMBC $11.34
  • IRMD $51.77
  • Analyst Decision
  • EMBC Hold
  • IRMD Strong Buy
  • Analyst Count
  • EMBC 3
  • IRMD 1
  • Target Price
  • EMBC $17.67
  • IRMD $72.00
  • AVG Volume (30 Days)
  • EMBC 655.8K
  • IRMD 39.3K
  • Earning Date
  • EMBC 05-08-2025
  • IRMD 05-01-2025
  • Dividend Yield
  • EMBC 5.39%
  • IRMD 1.32%
  • EPS Growth
  • EMBC 2.96
  • IRMD 11.11
  • EPS
  • EMBC 0.99
  • IRMD 1.50
  • Revenue
  • EMBC $1,107,700,000.00
  • IRMD $73,242,121.00
  • Revenue This Year
  • EMBC N/A
  • IRMD $10.58
  • Revenue Next Year
  • EMBC $0.99
  • IRMD $17.74
  • P/E Ratio
  • EMBC $11.45
  • IRMD $34.51
  • Revenue Growth
  • EMBC N/A
  • IRMD 11.71
  • 52 Week Low
  • EMBC $10.00
  • IRMD $40.18
  • 52 Week High
  • EMBC $21.48
  • IRMD $63.29
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 35.88
  • IRMD 47.77
  • Support Level
  • EMBC $11.58
  • IRMD $50.63
  • Resistance Level
  • EMBC $12.58
  • IRMD $53.06
  • Average True Range (ATR)
  • EMBC 0.77
  • IRMD 2.35
  • MACD
  • EMBC 0.01
  • IRMD 0.22
  • Stochastic Oscillator
  • EMBC 14.75
  • IRMD 64.81

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About IRMD iRadimed Corporation

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

Share on Social Networks: